Causal relationship between immune cells and the risk of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: A Mendelian randomization study

被引:0
|
作者
Cai, Xiaojing [1 ]
Li, Junhua [1 ]
Wu, Manyi [1 ]
Liu, Qingquan [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol, Wuhan, Peoples R China
来源
FASEB JOURNAL | 2024年 / 38卷 / 14期
关键词
ANCA; causal inference; genome-wide association study; immunity; myeloperoxidase; randomization analysis; REGULATORY T-CELLS; EOSINOPHILIC GRANULOMATOSIS; CD8(+) CD28(-); B-CELLS; SERUM; CD8(+)CD28(-); LYMPHOCYTES; EXPRESSION; REMISSION; INCREASES;
D O I
10.1096/fj.202400141R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare inflammatory disease categorized as antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. The majority of patients are ANCA-positive, predominantly against myeloperoxidase (MPO). Previous studies have predominantly concentrated on the association between EGPA and neutrophils, but recent research has emphasized the role of lymphocytes in the development of EGPA. The objective of our research was to examine the causal association between immune cells and MPO + ANCA EGPA. A two-sample bidirectional Mendelian randomization (MR) analysis was performed, which included 159 MPO + ANCA EGPA cases and 6688 controls and utilized Genome-Wind Associaton Studies (GWAS) summary statistics of immune traits from approximately 3757 individuals, encompassing around 22 million single nucleotide polymorphisms (SNPs). Our findings revealed that 23 immunophenotypes were associated with MPO + ANCA EGPA. Furthermore, the reverse MR analysis showed that MPO + ANCA EGPA had significant causal effects on three immunophenotypes within the Treg panel. By integrating existing research, our study unveiled the contributions of Tregs, B cells, and monocytes to the development of EGPA. Subgroup analysis specifically examined the roles of lymphocyte subtypes, cytokines, and their surface molecules in the pathogenic mechanisms of the disease. This comprehensive approach provides a novel perspective on the biological mechanisms and early intervention strategies for MPO + ANCA EGPA by focusing on immune cells.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody-associated vasculitis
    Sullivan, Megan M.
    Abril, Andy
    Aslam, Nabeel
    Ball, Colleen T.
    Berianu, Florentina
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [32] Outcome measures for antineutrophil cytoplasmic antibody-associated vasculitis
    Tomasson, Gunnar
    CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (01) : 38 - 44
  • [33] Maintenance Immunosuppression in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Cattran, Daniel C.
    Hladunewich, Michelle A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (06) : 818 - 821
  • [34] The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium
    Mcgovern, Dominic P.
    Jones, Rachel B.
    Jayne, David R. W.
    Smith, Rona M.
    DRUGS, 2025, 85 (03) : 325 - 341
  • [35] Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
    McGregor, JulieAnne G.
    Hogan, Susan L.
    Kotzen, Elizabeth S.
    Poulton, Caroline J.
    Hu, Yichun
    Negrete-Lopez, Roberto
    Kidd, Jason M.
    Katsanos, Suzanne L.
    Bunch, Donna O.
    Nachman, Patrick H.
    Falk, Ronald J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i123 - i131
  • [36] Current Landscape of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Lally, Lindsay
    Spiera, Robert
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (01) : 1 - +
  • [37] The role of complement in antineutrophil cytoplasmic antibody-associated vasculitis
    Trejo, Maria A. C. Wester
    Trouw, Leendert A.
    Bajema, Ingeborg M.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (01) : 3 - 8
  • [38] Renal Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Zonozi, Reza
    Niles, John L.
    Cortazar, Frank B.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (04) : 525 - +
  • [39] Relapse Prediction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Riogh, Eithne Nic an
    Little, Mark A.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (10) : 1473 - 1474
  • [40] Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Micheletti, Robert G.
    Fuxench, Zelma Chiesa
    Craven, Anthea
    Watts, Richard A.
    Luqmani, Raashid A.
    Merkel, Peter A.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (10) : 1741 - 1747